CMRX’s Stock Journey: What Investors Need to Know About Chimerix Inc’s Performance

Chimerix Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $1.78 on 03/02/23, and the lowest price during that time was $0.88, recorded on 11/10/23.

52-week price history of CMRX Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Chimerix Inc’s current trading price is -41.18% away from its 52-week high, while its distance from the 52-week low is 19.32%. The stock’s price range for this period has remained between $0.88 and $1.78. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.45 million for the day, which was noticeably higher compared to the shares’ average daily volume of 7.24 over the last three months.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Financial Performance and Market Capitalization

Chimerix Inc (CMRX) has experienced a quarterly rise of 10.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 93.33M.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9643, with a change in price of -0.0100. Similarly, Chimerix Inc recorded 407,719 in trading volume during the last 100 days, posting a change of -0.94%.

CMRX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CMRX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.

CMRX Stock Stochastic Average

As of today, the raw stochastic average of Chimerix Inc over the last 50 days is at 76.96%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 76.96%. Further, the company’s Stochastic %K and %D values for the last 20 days were 47.41% and 33.96%, respectively.

CMRX Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 9.09% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 7.42%. Over the past 30 days, the price of CMRX has fallen by 8.25%. And in the last five days, it has surged by 15.96%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts